PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report

Figure 2 The percentage and absolute numbers of lymphocyte subsets at baseline and after each cycle. A: The percentage of peripheral lymphocytes, including CD4⁺Temra, CD8⁺Temra, activated CD4⁺Temra, activated CD8⁺Temra, activated CD4⁺Tem, activated CD8⁺Tem and Tregs at baseline and after each cycle; B and C: Absolute numbers of peripheral lymphocytes subsets at baseline and after each cycle.